AGM/EGMJun 11, 2026, 07:06 AM
Orthofix Shareholders Approve 1.25M Share Increase for Stock Plan
AI Summary
Orthofix Medical Inc. held its 2026 Annual Meeting of Shareholders, where several key proposals were approved. Shareholders ratified Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan, increasing the number of shares available for issuance by 1,250,000. Additionally, all ten director nominees were elected, the advisory resolution to approve executive compensation passed, and Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Key Highlights
- Shareholders approved Amendment No. 5 to the Second Amended and Restated Stock Purchase Plan.
- The SPP Amendment increases shares available for issuance by 1,250,000.
- All ten director nominees were elected for a one-year term.
- Advisory resolution to approve executive compensation was approved with 24,480,474 votes in favor.
- Selection of Ernst & Young LLP as independent auditor for 2026 was ratified with 33,262,505 votes in favor.
- Total common shares eligible to vote were 40,385,869 as of April 13, 2026.
- A quorum was present with 34,776,676 shares represented at the meeting.
Price Impact
More from OFIX